Camber Capital Management as of Sept. 30, 2019
Portfolio Holdings for Camber Capital Management
Camber Capital Management holds 32 positions in its portfolio as reported in the September 2019 quarterly 13F filing
Company (Ticker) |
Portfolio Weight |
Valued At |
Change in Shares |
Share Count |
Share Price |
---|---|---|---|---|---|
Allergan | 13.3 | $252M | 1.5M | 168.29 | |
Mylan Nv | 12.0 | $228M | 12M | 19.78 | |
Perrigo Company (PRGO) | 5.0 | $95M | 1.7M | 55.89 | |
Brookdale Senior Living (BKD) | 5.0 | $95M | 13M | 7.58 | |
DaVita (DVA) | 4.5 | $86M | 1.5M | 57.07 | |
Alexion Pharmaceuticals | 4.4 | $83M | 850k | 97.94 | |
Biogen Idec (BIIB) | 4.3 | $82M | 350k | 232.82 | |
Bristol Myers Squibb (BMY) | 4.0 | $76M | 1.5M | 50.71 | |
Universal Health Services (UHS) | 3.9 | $74M | 500k | 148.75 | |
Hca Holdings (HCA) | 3.8 | $72M | 600k | 120.42 | |
Tenet Healthcare Corporation (THC) | 3.7 | $70M | 3.2M | 22.12 | |
Alkermes (ALKS) | 3.6 | $68M | 3.5M | 19.51 | |
Ascendis Pharma A S (ASND) | 3.3 | $63M | 650k | 96.32 | |
Sarepta Therapeutics (SRPT) | 3.0 | $57M | 750k | 75.32 | |
Nektar Therapeutics (NKTR) | 2.9 | $55M | 3.0M | 18.22 | |
AMAG Pharmaceuticals | 2.7 | $51M | 4.4M | 11.55 | |
Momenta Pharmaceuticals | 2.4 | $45M | 3.5M | 12.96 | |
Atara Biotherapeutics | 2.2 | $42M | 3.0M | 14.12 | |
Abbvie (ABBV) | 2.0 | $38M | 500k | 75.72 | |
Zymeworks | 2.0 | $37M | 1.5M | 24.80 | |
Novo Nordisk A/S (NVO) | 1.9 | $36M | 700k | 51.70 | |
United Therapeutics Corporation (UTHR) | 1.7 | $32M | 400k | 79.75 | |
Synthorx | 1.6 | $30M | 1.9M | 16.27 | |
Myriad Genetics (MYGN) | 1.5 | $29M | 1.0M | 28.63 | |
Cyclerion Therapeutics | 1.4 | $27M | 2.2M | 12.12 | |
GlaxoSmithKline | 1.1 | $21M | 500k | 42.68 | |
Wright Medical Group Nv | 0.8 | $16M | 750k | 20.63 | |
Glycomimetics (GLYC) | 0.8 | $15M | 3.5M | 4.31 | |
Translate Bio | 0.8 | $15M | 1.5M | 9.91 | |
Avrobio Ord (AVRO) | 0.4 | $7.1M | 500k | 14.12 | |
Sutro Biopharma (STRO) | 0.3 | $5.5M | 600k | 9.09 | |
Surgery Partners (SGRY) | 0.1 | $1.2M | 160k | 7.38 |